An Investigation of Molecular Defects Underlying Impaired Acute Inflammation in Crohn's Disease

Total Page:16

File Type:pdf, Size:1020Kb

An Investigation of Molecular Defects Underlying Impaired Acute Inflammation in Crohn's Disease AN INVESTIGATION OF MOLECULAR DEFECTS UNDERLYING IMPAIRED ACUTE INFLAMMATION IN CROHN’S DISEASE By Gavin William Sewell A thesis submitted to UCL for the degree of Doctor of Philosophy Division of Medicine 2011 1 I, Gavin William Sewell confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. 2 Abstract Mounting evidence suggests the pathogenesis of Crohn’s disease (CD) involves an impaired acute inflammatory response. Monocyte-derived macrophages from CD patients release deficient levels of pro-inflammatory cytokines in response to Escherichia coli, arising from post-translational trafficking abnormalities. In this thesis, the macrophage responses to microbial stimuli were further characterised, and the underlying molecular lesions investigated. Macrophage TNF release was attenuated in response to Escherichia coli, Candida albicans and Toll-like receptor (TLR) stimulation in CD. This deficit was unrelated to use of medication, age, gender and smoking status. Patients with stricturing and colonic disease demonstrated the most profound defects in response to TLR2 and TLR4 stimulation respectively. Genotyping for 34 known CD susceptibility polymorphisms revealed no detectable association between any individual variant and impaired TNF release. However in CD, TNF secretion in response to Escherichia coli was weakly correlated with overall genetic risk score. Macrophage sphingolipid and phospholipid compositions were subsequently investigated, given the prominent role of these molecules in vesicle trafficking. Mass spectrometric analysis revealed no gross abnormalities in CD macrophages, although a reduced percentage of phosphatidylinositol 16:0/18:1 was synthesised over 3 hours; the same species was also present at reduced levels in ileal biopsies. Given the heterogeneity of CD, a microarray outlier analysis strategy was developed to identify specific gene expression abnormalities in individual patients. A subset of patients had deficient expression of optineurin, a molecule implicated in vesicle trafficking and autophagy. These individuals shared a number of allelic variants, 3 which were associated with optineurin expression levels. Macrophages from these patients had attenuated TNF secretion downstream of TLR2. Concordantly, depletion of optineurin in THP-1 cells impaired TNF release after TLR2 activation. This study supports a role for immune deficiency in the pathogenesis of CD and identifies abnormal optineurin expression as a relevant molecular abnormality in a subset of patients. 4 Table of contents Acknowledgements........................................................................................................ 14 Statement of Collaborative Work ................................................................................ 16 List of abbreviations ..................................................................................................... 18 Chapter 1: Introduction ............................................................................................... 23 1.1 Clinical and epidemiological aspects of Inflammatory Bowel Disease ................ 23 1.1.1 Clinical presentation and management of Crohn’s disease ................................ 23 1.1.2 Ulcerative colitis and other inflammatory bowel diseases ............................. 28 1.1.3 Inflammatory bowel disease is associated with genetic and environmental factors ...................................................................................................................... 29 1.2 Theories of Crohn’s disease pathogenesis ............................................................. 30 1.2.1 Abnormal mucosal barrier function in Crohn’s disease ................................ 31 1.2.2. Infectious aetiology, ‘Dysbiosis’ and Crohn’s disease pathogenesis ............ 34 1.2.3 Autoimmunity .................................................................................................. 42 1.2.4 Immunodeficiency ........................................................................................... 43 1.2.5 Integrated models of Crohn’s disease pathogenesis....................................... 47 1.3 Impaired acute inflammation in Crohn’s disease .................................................. 48 1.3.1 Acute inflammation and the role of macrophages .......................................... 48 1.3.2 Mechanism of impaired neutrophil recruitment in Crohn’s disease .............. 52 1.3.3 Mechanism of defective macrophage cytokine secretion in Crohn’s disease . 54 1.3.4 Pathways of cytokine secretion and relevance to CD ..................................... 55 1.3.5 Other macrophage defects in Crohn’s disease ............................................... 59 1.3.6 Macrophage function in ulcerative colitis ...................................................... 60 1.4 Genetic factors in Crohn’s disease and their relationship to impaired acute inflammation ............................................................................................................... 61 1.4.1 NOD2 .............................................................................................................. 61 1.4.2 IBD5 ................................................................................................................ 63 1.4.3 ATG16L1, IRGM and autophagy .................................................................... 64 1.4.4 Other CD-susceptibility loci ........................................................................... 67 1.4.5 Limitations of GWAS and ‘Missing heritability’ ............................................ 69 5 1.4.6 The missing heritability of CD remains unexplained ..................................... 70 1.5 Outline of Thesis ................................................................................................... 71 1.5.1 Summary of background information ............................................................. 71 1.5.2 Summary of investigations conducted and hypotheses ................................... 73 Chapter 2: Materials and Methods ............................................................................. 75 2.1 Subject recruitment and selection .......................................................................... 75 2.2 Cell culture and assays .......................................................................................... 76 2.2.1 Preparation of stimuli for cell culture assays ................................................. 76 2.1.2 Primary macrophage isolation, culture and stimulation ................................ 77 2.1.3 THP-1 cell culture and stimulation ................................................................ 78 2.1.4 THP-1 cell transfection and siRNA knockdown ............................................. 78 2.1.5 TNF Bioassay .................................................................................................. 79 2.1.6 Multiplex cytokine measurement .................................................................... 80 2.1.7 MTT cell viability assay to estimate cell number ........................................... 81 2.1.8 Propidium iodide staining and flow cytometry ............................................... 82 2.1.9 SDS-PAGE and Western blotting ................................................................... 82 2.3 Genomic DNA preparation and analysis ............................................................... 84 2.3.1 Genomic DNA extraction ................................................................................ 84 2.3.2 Genotyping of Crohn’s disease associated polymorphisms ........................... 84 2.3.3 Calculation of genetic risk scores ................................................................... 86 2.3.4 Sequencing of OPTN region ........................................................................... 87 2.4 Lipid extraction and analysis ................................................................................. 89 2.4.1 Sphingolipid analysis of cultured macrophages ............................................. 89 2.4.2 BCA assay ....................................................................................................... 90 2.4.3 Preparation of samples for phospholipid analysis and stable isotope incubation ................................................................................................................ 91 2.4.4 Phospholipid extraction and analysis by electrospray ionisation mass spectrometry............................................................................................................. 92 2.5 RNA preparation and analysis ............................................................................... 94 2.5.1 RNA extraction from HC, CD and UC macrophages ..................................... 94 2.5.2 Microarray hybridisation ............................................................................... 95 6 2.5.3 Microarray data analysis................................................................................ 95 2.5.4 cDNA conversion and Quantitative PCR........................................................ 98 2.6 Statistical analysis ................................................................................................. 99 2.6.1 Analysis of cytokine secretion measurements, and relationships to phenotypes and genotypes (chapter 3).......................................................................................
Recommended publications
  • Atoh8 Is a Regulator of Intestinal Microfold Cell (M Cell) Differentiation Joel Johnson George1, Laura Martin-Diaz1, Markus Ojanen1, Keijo Viiri1
    bioRxiv preprint doi: https://doi.org/10.1101/2021.05.10.443378; this version posted May 10, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Atoh8 is a regulator of intestinal microfold cell (M cell) differentiation Joel Johnson George1, Laura Martin-Diaz1, Markus Ojanen1, Keijo Viiri1 1Faculty of Medicine and Health Technology, Tampere University Hospital, Tampere University Tampere, Finland. Grant Support: This work was supported by the Academy of Finland (no. 310011), Tekes (Business Finland) (no. 658/31/2015), Pediatric Research Foundation, Sigrid Jusélius Foundation, Mary och Georg C. Ehrnrooths Stiftelse, Laboratoriolääketieteen Edistämissäätiö sr. The funding sources played no role in the design or execution of this study or in the analysis and interpretation of the data. Abstract Intestinal microfold cells (M cells) are a dynamic lineage of epithelial cells that initiate mucosal immunity in the intestine. They are responsible for the uptake and transcytosis of microorganisms, pathogens and other antigens in the gastrointestinal tract. A mature M cell expresses a receptor Gp2 which binds to pathogens and aids in the uptake. Due to the rarity of these cells in the intestine, its development and differentiation remains yet to be fully understood. We recently demonstrated that polycomb repressive complex 2 (PRC2) is an epigenetic regulator of M cell development and 12 novel transcription factors including Atoh8 were revealed to be regulated by the PRC2. Here, we show that Atoh8 acts as a regulator of M cell differentiation; absence of Atoh8 led to a significant increase in the number of Gp2+ mature M cells and other M cell associated markers.
    [Show full text]
  • Assessing Immunomodulatory Effects of Penicillium Mycotoxins Using Bovine Macrophages Cell Line
    Assessing Immunomodulatory Effects of Penicillium Mycotoxins using Bovine Macrophages Cell Line by Se-Young Oh A Thesis presented to The University of Guelph In partial fulfilment of requirements for the degree of Doctor of Philosophy in Animal and Poultry Science (Toxicology) Guelph, Ontario, Canada © Se-Young Oh, December, 2014 ABSTRACT Assessing Immunomodulatory Effects of Penicillium Mycotoxins using Bovine Macrophages Cell Line Se-Young Oh Advisor: Dr. Niel A. Karrow University of Guelph , 2014 Co-Advisor: Dr. Herman J. Boermans The present study assessed the immunomodulatory effects on macrophages of the following Penicillium mycotoxins (PMs), including citrinin (CIT), ochratoxin A (OTA), patulin (PAT), mycophilic acid (MPA) and penicillic acid (PA), by using a bovine macrophage cell line (BoMacs). Initially, concentration-response curves for each of these PMs were established based on cell proliferation and viability. The potency of these PMs based on their IC50s (concentration that inhibits 50% cell proliferation) from highest to lowest was: 0.56 µM (PAT) > 12.88 µM (OTA) > 29.85 µM (PA) > 91.20 µM (CIT) > not determined (MPA). LC50s (concentrations that kill 50% of cells) for PAT and PA were determined to be 4.46 μM and 175.79 μM, respectively. In addition to this, binary mixtures of some PMs at their respective IC25 and lower were shown to have significant interactions on cell proliferation. CIT+OTA had significant synergism, while PAT+MPA, CIT+MPA, CIT+PA and MPA+PA exhibited significant antagonism. PAT+PA showed significant antagonism at their respective IC25s, but were antagonistic at lower concentrations. The PMs at their sub-lethal levels of IC25s also differentially altered the gene expression of the following cytokines, including IL-1α, IL-6, IL-10, IL-12, IL-23 and TGF-.
    [Show full text]
  • Screening of Surface Markers on Rat Intestinal Mucosa Microfold Cells by Using Laser Capture Microdissection Combined with Protein Chip Technology
    Int J Clin Exp Med 2014;7(4):932-939 www.ijcem.com /ISSN:1940-5901/IJCEM1401061 Original Article Screening of surface markers on rat intestinal mucosa microfold cells by using laser capture microdissection combined with protein chip technology Junyong Zhao*, Xiaoyu Li*, Qifeng Luo, Lei Xu, Lei Chen, Li Chai, Yixiang Huang, Lin Fang Department of Breast and Thyroid Surgery, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, 200072, China. *Equal contributors. Received January 21, 2014; Accepted April 10, 2014; Epub April 15, 2014; Published April 30, 2014 Abstract: Objective: The objective of this research was to investigate the possibility of screening surface markers on rat intestinal mucosa microfold cells (M cells) by using laser capture microdissection (LCM) combined with protein chip technology. Methods: We labeled rat intestinal mucosa microfold cells with Ulex europaeus agglutinin (UEA)-1 antibody and visualized these by immunofluorescence staining. Using the Proteome Profiler rat protein chip, we analyzed the protein expression profiles of LCM M-cells compared to lymph follicle-associated epithelial (FAE) cells, and we identified potential differences to screen for marker proteins. Results: M cells can be clearly distinguished from lymphoid FAE cells under the fluorescence microscope. We successfully cut, isolated, and obtained microfold and lymph FAE cells with more than 95% homogeneity. Six differentially expressed proteins were identified through comparison of the protein chip profiles of these 2 cell types. Among these, VEGF, LIX, CNTF, and IL-1α/IL-1F1 were found to be at significantly lower levels in M cells, IL-1ra/IL-1F3 and MIG/CXCL9 appeared in significantly higher levels in M cells (P < 0.05).
    [Show full text]
  • Surface Display of an Anti-DEC-205 Single Chain Fv Fragment in Lactobacillus Plantarum Increases Internalization and Plasmid
    Christophe et al. Microb Cell Fact (2015) 14:95 DOI 10.1186/s12934-015-0290-9 RESEARCH Open Access Surface display of an anti‑DEC‑205 single chain Fv fragment in Lactobacillus plantarum increases internalization and plasmid transfer to dendritic cells in vitro and in vivo Michon Christophe1,2, Katarzyna Kuczkowska3, Philippe Langella1,2, Vincent G H Eijsink3, Geir Mathiesen3 and Jean‑Marc Chatel1,2* Abstract Background: Lactic acid bacteria (LAB) are promising vehicles for delivery of a variety of medicinal compounds, including antigens and cytokines. It has also been established that LAB are able to deliver cDNA to host cells. To increase the efficiency of LAB-driven DNA delivery we have constructed Lactobacillus plantarum strains targeting DEC- 205, which is a receptor located at the surface of dendritic cells (DCs). The purpose was to increase uptake of bacterial cells, which could lead to improved cDNA delivery to immune cells. Results: Anti-DEC-205 antibody (aDec) was displayed at the surface of L. plantarum using three different anchoring strategies: (1) covalent anchoring of aDec to the cell membrane (Lipobox domain, Lip); (2) covalent anchoring to the cell wall (LPXTG domain, CWA); (3) non-covalent anchoring to the cell wall (LysM domain, LysM). aDec was success‑ fully expressed in all three strains, but surface location of the antibody could only be demonstrated for the two strains with cell wall anchors (CWA and LysM). Co-incubation of the engineered strains and DCs showed increased uptake when anchoring aDec using the CWA or LysM anchors. In a competition assay, free anti-DEC abolished the increased uptake, showing that the internalization is due to specific interactions between the DEC-205 receptor and aDec.
    [Show full text]
  • Immuno-Endocrine Interactions in Intestinal Inflammation
    IMMUNO-ENDOCRINE INTERACTIONS IN INTESTINAL INFLAMMATION PhD Thesis- Shajib, MS; McMaster University-Medical Sciences Immuno-endocrine interactions in intestinal inflammation By Md. Sharif Shajib, BSc. (Hons) A Thesis Submitted to the School of Graduate Studies in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy McMaster University © Copyright by Md. Sharif Shajib, 2017. PhD Thesis- Shajib, MS; McMaster University-Medical Sciences Descriptive notes Doctor of Philosophy (2017) McMaster University, Hamilton, Ontario (Medical Sciences) TITLE Immuno-endocrine interactions in intestinal inflammation AUTHOR Md. Sharif Shajib, BSc. (Hons) SUPERVISOR Dr. Waliul I. Khan NUMBER OF PAGES: XX, 292. II PhD Thesis- Shajib, MS; McMaster University-Medical Sciences Lay abstract The gut produces most of the serotonin found in our body, where it regulates many normal functions. A group of special cells, named enterochromaffin cells, produces nearly all of the serotonin in the gut. In diseases of the gut, especially ones that involve inflammation resulting in symptoms like abdominal pain, diarrhea and bleeding, the number of these cells and serotonin concentration are different from that in the normal gut. I found that these changes are controlled by a particular protein produced by immune cells, called interleukin-13, and alteration in serotonin levels, in turn, contributes to the inflammatory process. Our laboratory experiments with cells and animals establish this connection between interleukin-13 and serotonin in gut inflammation. We further confirm this association between interleukin-13 and serotonin in human inflammatory bowel disease. Moreover, we identify a potential genetic cause of these changes in serotonin concentrations which may ultimately result in inflammatory bowel disease.
    [Show full text]
  • University of Alberta DENDRITIC CELL-TARGETED NANOPARTICLES for the DELIVERY of DNA and PROTEIN VACCINES by Dharmendra Raghuwans
    University of Alberta DENDRITIC CELL-TARGETED NANOPARTICLES FOR THE DELIVERY OF DNA AND PROTEIN VACCINES By Dharmendra Raghuwanshi A thesis submitted to the Faculty of Graduate Studies and Research in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY in Pharmaceutical Sciences Faculty of Pharmacy and Pharmaceutical Sciences © Dharmendra Raghuwanshi Fall 2012 Edmonton, Alberta Permission is hereby granted to the University of Alberta Libraries to reproduce single copies of this thesis and to lend or sell such copies for private, scholarly or scientific research purposes only. Where the thesis is converted to, or otherwise made available in digital form, the University of Alberta will advise potential users of the thesis of these terms. The author reserves all other publication and other rights in association with the copyright in the thesis and, except as herein before provided, neither the thesis nor any substantial portion thereof may be printed or otherwise reproduced in any material form whatsoever without the author's prior written permission. Dedication I dedicate this thesis to my beloved Mother with all my love and respect. Your memories and affection will always be alive in my heart. ABSTRACT Dendritic cells (DCs) play a central role in shaping antigen-specific immune response. Antibody-mediated antigen targeting to DC-specific surface receptors is a promising approach to enhance vaccine efficacy. The objective of this thesis was to develop DC-targeted nanoparticulate formulations for the delivery of DNA and protein antigen using a novel strategy. The approach involved use of a two- component DC targeted delivery system for enhanced immune response.
    [Show full text]
  • Nomina Histologica Veterinaria, First Edition
    NOMINA HISTOLOGICA VETERINARIA Submitted by the International Committee on Veterinary Histological Nomenclature (ICVHN) to the World Association of Veterinary Anatomists Published on the website of the World Association of Veterinary Anatomists www.wava-amav.org 2017 CONTENTS Introduction i Principles of term construction in N.H.V. iii Cytologia – Cytology 1 Textus epithelialis – Epithelial tissue 10 Textus connectivus – Connective tissue 13 Sanguis et Lympha – Blood and Lymph 17 Textus muscularis – Muscle tissue 19 Textus nervosus – Nerve tissue 20 Splanchnologia – Viscera 23 Systema digestorium – Digestive system 24 Systema respiratorium – Respiratory system 32 Systema urinarium – Urinary system 35 Organa genitalia masculina – Male genital system 38 Organa genitalia feminina – Female genital system 42 Systema endocrinum – Endocrine system 45 Systema cardiovasculare et lymphaticum [Angiologia] – Cardiovascular and lymphatic system 47 Systema nervosum – Nervous system 52 Receptores sensorii et Organa sensuum – Sensory receptors and Sense organs 58 Integumentum – Integument 64 INTRODUCTION The preparations leading to the publication of the present first edition of the Nomina Histologica Veterinaria has a long history spanning more than 50 years. Under the auspices of the World Association of Veterinary Anatomists (W.A.V.A.), the International Committee on Veterinary Anatomical Nomenclature (I.C.V.A.N.) appointed in Giessen, 1965, a Subcommittee on Histology and Embryology which started a working relation with the Subcommittee on Histology of the former International Anatomical Nomenclature Committee. In Mexico City, 1971, this Subcommittee presented a document entitled Nomina Histologica Veterinaria: A Working Draft as a basis for the continued work of the newly-appointed Subcommittee on Histological Nomenclature. This resulted in the editing of the Nomina Histologica Veterinaria: A Working Draft II (Toulouse, 1974), followed by preparations for publication of a Nomina Histologica Veterinaria.
    [Show full text]
  • And Oropharynx-Associated Lymphoid Tissue of Sheep T ⁎ Vijay Kumar Saxenaa,B, Alejandra Diaza,C, Jean-Pierre Y
    Veterinary Immunology and Immunopathology 208 (2019) 1–5 Contents lists available at ScienceDirect Veterinary Immunology and Immunopathology journal homepage: www.elsevier.com/locate/vetimm Identification and characterization of an M cell marker in nasopharynx- and oropharynx-associated lymphoid tissue of sheep T ⁎ Vijay Kumar Saxenaa,b, Alejandra Diaza,c, Jean-Pierre Y. Scheerlincka, a Centre for Animal Biotechnology, Faculty of Veterinary and Agricultural Sciences, University of Melbourne, Victoria, 3010, Australia b Division of Animal Physiology and Biochemistry, ICAR-Central Sheep and Wool Research Institute, Avikanagar, Tonk, Rajasthan, 304501, India c Laboratorio de Inmunología, Departamento SAMP, Centro de Investigación Veterinaria de Tandil (CIVETAN-CONICET), Facultad de Ciencias Veterinarias, Universidad Nacional del Centro de la Pcia. de Bs. As., Tandil, 7000, Buenos Aires, Argentina ARTICLE INFO ABSTRACT Keywords: M cells play a pivotal role in the induction of immune responses within the mucosa-associated lymphoid tissues. Sheep M cells exist principally in the follicle-associated epithelium (FAE) of the isolated solitary lymphoid follicles as M cells well as in the lymphoid follicles of nasopharynx-associated lymphoid tissue and gut associated lymphoid tissue NALT (GALT). Through lymphatic cannulation it is possible to investigate local immune responses induced following Mucosal immunity nasal Ag delivery in sheep. Hence, identifying sheep M cell markers would allow the targeting of M cells to offset Biomarker the problem of trans-epithelial Ag delivery associated with inducing mucosal immunity. Sheep cDNA from the GP2 tonsils of the oropharynx and nasopharynx was PCR amplified using Glycoprotein-2 (GP2)-specific primers and expressed as a poly-His-tagged recombinant sheep GP2 (56 kDa) in HEK293 cells.
    [Show full text]
  • Science Journals
    SCIENCE IMMUNOLOGY | RESEARCH RESOURCE T CELL MEMORY Copyright © 2020 The Authors, some rights reserved; Early precursors and molecular determinants of tissue- exclusive licensee + American Association resident memory CD8 T lymphocytes revealed by for the Advancement of Science. No claim single-cell RNA sequencing to original U.S. Nadia S. Kurd1*†, Zhaoren He2,3*, Tiani L. Louis1, J. Justin Milner3, Kyla D. Omilusik3, Government Works Wenhao Jin2, Matthew S. Tsai1, Christella E. Widjaja1, Jad N. Kanbar1, Jocelyn G. Olvera1, Tiffani Tysl1, Lauren K. Quezada1, Brigid S. Boland1, Wendy J. Huang2, Cornelis Murre3, Ananda W. Goldrath3, Gene W. Yeo2,4‡, John T. Chang1,5‡§ + During an immune response to microbial infection, CD8 T cells give rise to distinct classes of cellular progeny that coordinately mediate clearance of the pathogen and provide long-lasting protection against reinfection, including Downloaded from a subset of noncirculating tissue-resident memory (TRM) cells that mediate potent protection within nonlymphoid + tissues. Here, we used single-cell RNA sequencing to examine the gene expression patterns of individual CD8 T cells in the spleen and small intestine intraepithelial lymphocyte (siIEL) compartment throughout the course of their differentiation in response to viral infection. These analyses revealed previously unknown transcriptional + heterogeneity within the siIEL CD8 T cell population at several stages of differentiation, representing functionally distinct TRM cell subsets and a subset of TRM cell precursors within the tissue early in infection. Together, these http://immunology.sciencemag.org/ + findings may inform strategies to optimize CD8 T cell responses to protect against microbial infection and cancer. INTRODUCTION composed of distinct subsets that play unique roles in mediating CD8+ T cells responding to microbial challenge differentiate into protective immunity.
    [Show full text]
  • NIH Public Access Author Manuscript Eur J Immunol
    NIH Public Access Author Manuscript Eur J Immunol. Author manuscript; available in PMC 2010 May 5. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Eur J Immunol. 2008 January ; 38(1): 20±29. doi:10.1002/eji.200737799. Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205/CD205 positive mouse dendritic cells Yoonkyung Do1, Chae Gyu Park1, Young-Sun Kang1,3, Sung Ho Park1, Rebecca M. Lynch1, Haekyung Lee1, Bradford S. Powell2, and Ralph M. Steinman1,* 1 Laboratory of Cellular Physiology and Immunology and Chris Browne Center for Immunology and Immune Diseases, The Rockefeller University, New York, NY 10065 2 U. S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 3 Department of Biomedical Science and Technology, Institute of Biomedical Science and Technology, Konkuk University, 1 Hwayang-dong, Kwangjin-gu, Seoul 143-701, Republic of Korea SUMMARY There is a need for a more efficient vaccine against the bacterium Y. pestis, the agent of pneumonic plague. The F1-LcrV subunit vaccine in alhydrogel is known to induce humoral immunity. In this study, we utilized dendritic cells to investigate cellular immunity. We genetically engineered the LcrV virulence protein into the αDEC-205/CD205 monoclonal antibody and thereby targeted the conjugated protein directly to mouse DEC-205+ DCs in situ. We observed antigen-specific CD4+ T cell immunity measured by intracellular staining for interferon- γ in three different mouse strains (C57BL/6, BALB/c, and C3H/HeJ), while we could not observe such T cell responses with F1-V vaccine in alhydrogel.
    [Show full text]
  • Molecular Mechanisms of Neuroprotection by an Alternative Drug Scutellaria Lateriflora by Madhukar Lohani a Dissertation Submitt
    Molecular Mechanisms of Neuroprotection by an Alternative Drug Scutellaria lateriflora by Madhukar Lohani A dissertation submitted to the Graduate Faculty of Auburn University in partial fulfillment of the requirements for the Degree of Doctor of Philosophy Auburn, Alabama August 02, 2014 Key words: American skullcap, Anxiety, Memory, Neuroprotection, Scutellaria lateriflora Copyright 2014 by Madhukar Lohani Approved by Barbara W Kemppainen, Chair, Professor of Anatomy, Physiology and Pharmacology Dean D Schwartz, Associate Professor of Anatomy, Physiology and Pharmacology Kellye Joiner, Associate Professor of Pathobiology Muralikrishnan Dhanasekaran, Associate Professor of Pharmacal sciences Frederik W Van Ginkel, Associate Professor of Pathobiology i Abstract Anxiety is one of the most prevalent neuropsychological disorders around the world. In the United States of America (USA), it is a serious health problem affecting a large number of people and is considered as one of the common disorder seen in the primary health care. Based on the current understanding of the pathologic mechanisms of anxiety, there are limited pharmacological and non-pharmacological therapies. Benzodiazepine (the current first line of therapy) has severe adverse effects such as anterograde amnesia, tolerance, psychomotor impairment, memory disruption, impaired psychomotor function, paradoxical anxiety or aggression, risks of accidents and even mortality. A double blind, placebo- controlled clinical trial indicated that commercial preparations of Scutellaria lateriflora have therapeutic benefits in anxiety with no evidence of toxicity. The purpose of this study was to examine the biological activities of S. lateriflora that may contribute to its neuroprotective mechanisms. The research study was conducted in four phases. The first two experimental approaches determined anti-oxidative potential and protective activities of S.
    [Show full text]
  • Materials for Oral Delivery of Proteins and Peptides
    REVIEWS Materials for oral delivery of proteins and peptides Tyler D. Brown 1,2, Kathryn A. Whitehead 3,4 and Samir Mitragotri 1,2* Abstract | Throughout history , oral administration has been regarded as the most convenient mode of drug delivery , as it requires minimal expertise and invasiveness. Although oral delivery works well for small-molecule drugs, oral delivery of macromolecules (particularly proteins and peptides) has been limited by acidic conditions in the stomach and low permeability across the intestinal epithelium. Accordingly , the large numbers of biologic drugs that have become available in the past 10 years typically require administration by injection or infusion. As such, a renewed emphasis has been placed on the development of novel materials that overcome the physiological challenges of oral delivery for macromolecular agents. This Review provides an overview of physiological barriers to the oral delivery of biologics and highlights the advances made in materials across various length scales, from small molecules to macroscopic devices. This Review also describes the current status of materials for oral delivery of protein and peptide drugs. The past decade has seen an increase in the number route13. Unfortunately, barring some very small pep­ of new drugs approved by the US Food and Drug Admin­ tides such as ciclosporin, oral delivery is not a currently istration (FDA), leading to an all­ time record number available option for protein and antibody drugs14. These of 59 novel drug approvals in 2018. Drugs for oral use macro molecular agents have prohibitively low oral bio­ continue to dominate the therapeutic landscape, encom­ availability due to several features of the gastrointestinal passing over 50% of these approvals1.
    [Show full text]